Elevance Health Exceeds Earnings and Revenue Estimates, Raises FY26 Guidance
Elevance Health reported Q2 non-GAAP earnings per share of $7.45, surpassing estimates by $1.24, with revenue reaching $49.83 billion, beating expectations by $1.2 billion. The company raised its full-year FY26 diluted EPS guidance to at least $20.10 and adjusted diluted EPS guidance to at least $27.00.
Tickers: $ELV
Topics: Earnings Guidance Update